Tags

Type your tag names separated by a space and hit enter

Can FESS combined with submucosal resection (SMR)/septoplasty reduce revision rate?
Otolaryngol Head Neck Surg. 2014 Oct; 151(4):700-5.OH

Abstract

OBJECTIVES

Our study was designed to ascertain the outcomes of functional endoscopic sinus surgery (FESS) combined with submucosal resection (SMR)/septoplasty in reducing FESS revision rates.

STUDY DESIGN

Retrospective population-based study.

SETTING

Academic tertiary medical center.

SUBJECTS AND METHODS

By using the Taiwan Longitudinal Health Insurance Database, we obtained the patients who underwent FESS for chronic rhinosinusitis. These patients were divided into 2 groups: the control group (FESS alone) and the study group (FESS combined with SMR). The primary outcome was the revision operative rate.

RESULTS

In total, 4484 patients who had undergone FESS were recruited into this study. The number of patients who underwent revision FESS was 528 (11.78%). In our sample, 80.45% of patients received FESS alone, whereas 19.54% of the patients underwent concurrent SMR/septoplasty during FESS. There are more female patients and older patients in the control group than in the study group. The revision rates of these 2 groups were significantly different (12.36% vs 9.36%, respectively; P = .016). Moreover, logistic regression analysis came out that patients in the control group had a higher revision rates than those in the study group. Male patients and younger patients were found to have higher revision rates. In addition, patients with asthma or allergic rhinitis had higher revision rates compared with those patients without these 2 comorbidities.

CONCLUSIONS

This study showed an association between FESS combined with concurrent SMR/septoplasty and less incidence of revision rate of FESS. Patients with asthma or allergic rhinitis have an increased risk of requiring more revision surgeries after FESS.

Authors+Show Affiliations

Departments of Otolaryngology, China Medical University Hospital, Taichung, Taiwan.Departments of Otolaryngology, China Medical University Hospital, Taichung, Taiwan College of Medicine, China Medical University, Taichung, Taiwan d3485@mail.cmuh.org.tw.Departments of Otolaryngology, China Medical University Hospital, Taichung, Taiwan.Departments of Otolaryngology, China Medical University Hospital, Taichung, Taiwan College of Medicine, China Medical University, Taichung, Taiwan.Departments of Otolaryngology, China Medical University Hospital, Taichung, Taiwan College of Medicine, China Medical University, Taichung, Taiwan.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

25146305

Citation

Chang, Chan-Chi, et al. "Can FESS Combined With Submucosal Resection (SMR)/septoplasty Reduce Revision Rate?" Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, vol. 151, no. 4, 2014, pp. 700-5.
Chang CC, Tai CJ, Ng TY, et al. Can FESS combined with submucosal resection (SMR)/septoplasty reduce revision rate? Otolaryngol Head Neck Surg. 2014;151(4):700-5.
Chang, C. C., Tai, C. J., Ng, T. Y., Tsou, Y. A., & Tsai, M. H. (2014). Can FESS combined with submucosal resection (SMR)/septoplasty reduce revision rate? Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery, 151(4), 700-5. https://doi.org/10.1177/0194599814543778
Chang CC, et al. Can FESS Combined With Submucosal Resection (SMR)/septoplasty Reduce Revision Rate. Otolaryngol Head Neck Surg. 2014;151(4):700-5. PubMed PMID: 25146305.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Can FESS combined with submucosal resection (SMR)/septoplasty reduce revision rate? AU - Chang,Chan-Chi, AU - Tai,Chih-Jaan, AU - Ng,Teik-Ying, AU - Tsou,Yung-An, AU - Tsai,Ming-Hsui, Y1 - 2014/08/21/ PY - 2014/8/23/entrez PY - 2014/8/26/pubmed PY - 2015/6/2/medline KW - SMR KW - allergic rhinitis KW - asthma KW - deviated nasal septum KW - revision FESS KW - septoplasty SP - 700 EP - 5 JF - Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery JO - Otolaryngol Head Neck Surg VL - 151 IS - 4 N2 - OBJECTIVES: Our study was designed to ascertain the outcomes of functional endoscopic sinus surgery (FESS) combined with submucosal resection (SMR)/septoplasty in reducing FESS revision rates. STUDY DESIGN: Retrospective population-based study. SETTING: Academic tertiary medical center. SUBJECTS AND METHODS: By using the Taiwan Longitudinal Health Insurance Database, we obtained the patients who underwent FESS for chronic rhinosinusitis. These patients were divided into 2 groups: the control group (FESS alone) and the study group (FESS combined with SMR). The primary outcome was the revision operative rate. RESULTS: In total, 4484 patients who had undergone FESS were recruited into this study. The number of patients who underwent revision FESS was 528 (11.78%). In our sample, 80.45% of patients received FESS alone, whereas 19.54% of the patients underwent concurrent SMR/septoplasty during FESS. There are more female patients and older patients in the control group than in the study group. The revision rates of these 2 groups were significantly different (12.36% vs 9.36%, respectively; P = .016). Moreover, logistic regression analysis came out that patients in the control group had a higher revision rates than those in the study group. Male patients and younger patients were found to have higher revision rates. In addition, patients with asthma or allergic rhinitis had higher revision rates compared with those patients without these 2 comorbidities. CONCLUSIONS: This study showed an association between FESS combined with concurrent SMR/septoplasty and less incidence of revision rate of FESS. Patients with asthma or allergic rhinitis have an increased risk of requiring more revision surgeries after FESS. SN - 1097-6817 UR - https://www.unboundmedicine.com/medline/citation/25146305/Can_FESS_combined_with_submucosal_resection__SMR_/septoplasty_reduce_revision_rate DB - PRIME DP - Unbound Medicine ER -